Overview
ORNATE-India is made up five work packages (WP) led by a multidisciplinary team of researchers in the UK and India.
ORNATE-India is made up five work packages (WP) led by a multidisciplinary team of researchers in the UK and India.
Lorem ipsum dolor sit amet, consectetlit. Aenean eget dolor.
Lorem ipsum dolor sit amet, consectetlit. Aenean eget dolor.
Lorem ipsum dolor sit amet
Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Nullam sagittis. Suspendisse pulvinar, augue ac venenatis condic pellentesque. Curae; Fusce id purus. Ut varius tincidunt libero.
Aenean vulputate eleifend tellus.
Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis.
Lorem ipsum dolor sit amet, consectetlit. Aenean eget dolor.
Lorem ipsum dolor sit amet
Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Nullam sagittis. Suspendisse pulvinar, augue ac venenatis condic pellentesque. Curae; Fusce id purus. Ut varius tincidunt libero.
Aenean vulputate eleifend tellus.
Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis.
Lorem ipsum dolor sit amet, consectetlit. Aenean eget dolor.
Lorem ipsum dolor sit amet
Donec elit libero, sodales nec, volutpat a, suscipit non, turpis. Nullam sagittis. Suspendisse pulvinar, augue ac venenatis condic pellentesque. Curae; Fusce id purus. Ut varius tincidunt libero.
Aenean vulputate eleifend tellus.
Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis.
Screening for diabetic retinopathy will be carried out using smartphone-based mydriatic retinal imaging (Remidio Innovative Solutions, Bengaluru, India).
Screening for diabetic retinopathy using a smartphone-based fundus camera
The staff at the FHCs will collate the data at primary care level. The retinal images will be linked to the eHealth register and uploaded to the Regional Institute of Ophthalmology (RIO) where the image will be graded by optometrists and results reported back to FHCs. Annual recall of patients with non-referable retinopathy will be arranged.
If patients are diagnosed with diabetic retinopathy and require treatment they are referred to a District Hospital (DH) for laser surgery or to RIO if anti-VEGF treatment is necessary. Treatment outcomes at DH and RIO will be collected as below.
a) Healthy retina
b) diabetic retinopathy- hemorrhages and cotton wool spots
The key outcome of the Kerala Study is the number of cases of severe visual impairment or blindness due to sight threatening diabetic retinopathy averted as a result of the new care pathway and quality-adjusted life-year (QALY) gains arising from cases averted. We will use EQ5D, an instrument to measure of health-related quality of life, with vision bolt-on data where data is available and detailed cost data. At the conclusion of this study, we hope to assess the effectiveness and implementation of a complex diabetic retinopathy care pathway integrating care at primary, secondary and tertiary care, covering a proportion of the diabetic population in Thiruvananthapuram. This pilot data will be useful for Kerala and will set the scene for a policy for State-wide Diabetes Complications Screening and Treatment Pathway with clinical impact on the patient, impact on the community, impact on staff and economic impact on family and public purse and integrating it to primary care practice.
Last updated: 22nd November 2018